Image:MonoclonalAb.jpg
From Wikipedia, the free encyclopedia
No higher resolution available.
MonoclonalAb.jpg (427 × 285 pixels, file size: 27 KB, MIME type: image/jpeg)
Monoclonal antibodies for cancer. ADEPT, antibody directed enzyme prodrug therapy; ADCC, antibody dependent cell-mediated cytotoxicity; CDC, complement dependent cytotoxicity; MAb, monoclonal antibody; scFv, single-chain Fv fragment. Modified from Carter P: Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-129;
This work has been released into the public domain by the copyright holder. This applies worldwide. In case this is not legally possible: |
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Dimensions | User | Comment | |
---|---|---|---|---|
current | 14:23, 16 December 2004 | 427×285 (27 KB) | Ramujana (Talk | contribs) | (Monoclonal antibodies for cancer; Modified from Carter P: Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-129; {{CopyrightedFreeUse}} ) |
- Search for duplicate files
- Edit this file using an external application
See the setup instructions for more information.
File links
- Monoclonal antibodies
- Basiliximab
- Gemtuzumab ozogamicin
- OKT3
- Efalizumab
- Palivizumab
- Monoclonal antibody therapy
- Panitumumab
- Apolizumab
- Bapineuzumab
- Ecromeximab
- Oregovomab
- Lemalesomab
- Sulesomab
- Denosumab
- Gavilimomab
- Afelimomab
- Faralimomab
- Catumaxomab
- Ertumaxomab
- Adecatumumab
- Anetumumab
- Altumomab
- Anatumomab mafenatox
- Arcitumomab
- Aselizumab
- Atorolimumab
- Bavituximab
- Bectumomab
- Bertilimumab
- Biciromab brallobarbital
- Bivatuzumab mertansine
- Cantuzumab mertansine
- Cedelizumab
- Clenoliximab
- Ipilimumab
- Lerdelimumab
- Metelimumab
- Zanolimumab
- Ziralimumab
- Dorlimomab aritox
- Telimomab aritox
- Zolimomab aritox
- Elsilimomab
- Inolimomab
- Odulimomab
- Vepalimomab
- Galiximab
- Gomiliximab
- Golimumab
- Maslimomab
- Keliximab
- Lumiliximab
- Teneliximab
- Vapaliximab
- Tremelimumab
- Erlizumab
- Fontolizumab
- Ocrelizumab
- Pascolizumab
- Pexelizumab
- Reslizumab
- Rovelizumab
- Ruplizumab
- Siplizumab
- Talizumab
- Tocilizumab
- Toralizumab
- Visilizumab
- Pemtumomab
- Mepolizumab
- Exbivirumab
- Libivirumab
- Regavirumab
- Sevirumab
- Tuvirumab
- Felvizumab
- Motavizumab
- Inotuzumab ozogamicin
- Lintuzumab
- Matuzumab
- Nimotuzumab
- Sibrotuzumab
- Sontuzumab
- Tacatuzumab tetraxetan
- Tadocizumab
- Tefibazumab
- Tucotuzumab celmoleukin
- Epratuzumab
- Atlizumab
- Nerelimomab
- Urtoxazumab
- Pagibaximab
- Duntumumab
- Iratumumab
- Lexatumumab
- Mapatumumab
- Ofatumumab
- Pritumumab
- Votumumab
View more links to this file.